Richard Vosser
Stock Analyst at J.P. Morgan
(3.98)
# 1,807
Out of 5,119 analysts
1073
Total ratings
53.4%
Success rate
3.7%
Average return
Main Sectors:
Stocks Rated by Richard Vosser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: SAN Sanofi | Reiterated: Hold | €95.00 | €83.74 | +13.45% | 171 | Nov 4, 2026 | |
| ETR: BAYN Bayer Aktiengesellschaft | Reiterated: Buy | €61.00 | €55.58 | +9.75% | 152 | Nov 3, 2026 | |
| SWX: GALD Galderma Group AG | Reiterated: Buy | CHF 220.00 | CHF 191.75 | +14.73% | 1 | Oct 29, 2026 | |
| SWX: NOVN Novartis AG | Reiterated: Buy | CHF 145.00 | CHF 133.08 | +8.96% | 122 | Oct 29, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Hold | CHF 325.00 → CHF 335.00 | CHF 390.30 | -14.17% | 193 | Oct 26, 2026 | |
| LON: AZN AstraZeneca PLC | Reiterated: Buy | 16,000p | 13,930p | +14.86% | 43 | Oct 26, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Buy | €295.00 | €290.00 | +1.72% | 78 | Oct 22, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Reiterated: Buy | €260.00 | €225.80 | +15.15% | 31 | Oct 22, 2026 | |
| EPA: IPN Ipsen S.A. | Reiterated: Hold | n/a | $158.70 | - | 16 | Jun 29, 2026 | |
| ETR: MRK Merck KGaA | Reiterated: Buy | €150.00 | €148.75 | +0.84% | 145 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $1,890.00 | - | 7 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $925 → $1,100 | $927.21 | +18.64% | 2 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 3.50 → CHF 3.00 | CHF 2.60 | +15.38% | 15 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $40.31 | - | 21 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $162.55 | - | 4 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $4 | $3.14 | n/a | 8 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €250.00 → €260.00 | €227.00 | n/a | 17 | Jul 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 645.00 → CHF 650.00 | CHF 663.40 | n/a | 15 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €3.00 → €3.50 | €0.80 | n/a | 6 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $53 → $38 | $15.33 | n/a | 7 | Dec 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €44.62 | €53.25 | n/a | 1 | Jan 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 3,000p | 1,650p | n/a | 7 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $176 | $38.59 | n/a | 1 | Mar 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $59.37 | n/a | 3 | Dec 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 | $161.88 | n/a | 1 | Jul 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $205 → $200 | $33.45 | n/a | 2 | Mar 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | €185.00 | €29.62 | n/a | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $53.63 | n/a | 1 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $47.04 | n/a | 1 | Apr 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 | $8.43 | n/a | 1 | Jan 4, 2017 |
Sanofi
Nov 4, 2026
Reiterated: Hold
Price Target: €95.00
Current: €83.74
Upside: +13.45%
Bayer Aktiengesellschaft
Nov 3, 2026
Reiterated: Buy
Price Target: €61.00
Current: €55.58
Upside: +9.75%
Galderma Group AG
Oct 29, 2026
Reiterated: Buy
Price Target: CHF 220.00
Current: CHF 191.75
Upside: +14.73%
Novartis AG
Oct 29, 2026
Reiterated: Buy
Price Target: CHF 145.00
Current: CHF 133.08
Upside: +8.96%
Roche Holding AG
Oct 26, 2026
Reiterated: Hold
Price Target: CHF 325.00 → CHF 335.00
Current: CHF 390.30
Upside: -14.17%
AstraZeneca PLC
Oct 26, 2026
Reiterated: Buy
Price Target: 16,000p
Current: 13,930p
Upside: +14.86%
Sartorius Aktiengesellschaft
Oct 22, 2026
Reiterated: Buy
Price Target: €295.00
Current: €290.00
Upside: +1.72%
Sartorius Stedim Biotech S.A.
Oct 22, 2026
Reiterated: Buy
Price Target: €260.00
Current: €225.80
Upside: +15.15%
Ipsen S.A.
Jun 29, 2026
Reiterated: Hold
Price Target: n/a
Current: $158.70
Upside: -
Merck KGaA
Jun 1, 2026
Reiterated: Buy
Price Target: €150.00
Current: €148.75
Upside: +0.84%
Dec 23, 2025
Reiterated: Sell
Price Target: n/a
Current: $1,890.00
Upside: -
Dec 8, 2025
Reiterated: Buy
Price Target: $925 → $1,100
Current: $927.21
Upside: +18.64%
Dec 8, 2025
Reiterated: Hold
Price Target: CHF 3.50 → CHF 3.00
Current: CHF 2.60
Upside: +15.38%
Nov 24, 2025
Reiterated: Buy
Price Target: n/a
Current: $40.31
Upside: -
Nov 20, 2025
Reiterated: Hold
Price Target: n/a
Current: $162.55
Upside: -
Sep 3, 2025
Reiterated: Hold
Price Target: $4.5 → $4
Current: $3.14
Upside: n/a
Jul 22, 2025
Reiterated: Buy
Price Target: €250.00 → €260.00
Current: €227.00
Upside: n/a
Dec 3, 2024
Reiterated: Buy
Price Target: CHF 645.00 → CHF 650.00
Current: CHF 663.40
Upside: n/a
Dec 3, 2024
Reiterated: Hold
Price Target: €3.00 → €3.50
Current: €0.80
Upside: n/a
Dec 5, 2023
Reiterated: Hold
Price Target: $53 → $38
Current: $15.33
Upside: n/a
Jan 3, 2023
Upgraded: Buy
Price Target: €44.62
Current: €53.25
Upside: n/a
Sep 27, 2021
Reiterated: Buy
Price Target: 3,000p
Current: 1,650p
Upside: n/a
Mar 18, 2021
Reiterated: Buy
Price Target: $176
Current: $38.59
Upside: n/a
Dec 21, 2020
Reiterated: Buy
Price Target: n/a
Current: $59.37
Upside: n/a
Jul 28, 2020
Reiterated: Buy
Price Target: $138
Current: $161.88
Upside: n/a
Mar 2, 2020
Reiterated: Hold
Price Target: $205 → $200
Current: $33.45
Upside: n/a
Jan 6, 2020
Downgraded: Hold
Price Target: €185.00
Current: €29.62
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $53.63
Upside: n/a
Apr 11, 2017
Upgraded: Hold
Price Target: n/a
Current: $47.04
Upside: n/a
Jan 4, 2017
Upgraded: Buy
Price Target: $22
Current: $8.43
Upside: n/a